No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MAX240517P17500
- 0.10
- -1.01-90.99%
15min DelayClose May 10 15:59 ET
0.10High0.10Low
0.10Open1.11Pre Close1 Volume2 Open Interest17.50Strike Price10.00Turnover81.25%IV-12.65%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.10Time Value100Contract SizeAmericanOptions Type-0.0974Delta0.0825Gamma199.20Leverage Ratio-0.0286Theta-0.0003Rho-19.39Eff Leverage0.0044Vega
Intraday
- 5D
- 1D
News
White Mountains Insurance Group Ltd (WTM) Q1 2024 Earnings: Solid Performance With Key Growth ...
MediaAlpha Closes Secondary Offering
White Mountains Insurance Group, Ltd. (NYSE: WTM) announced today that MediaAlpha, Inc. ("MediaAlpha") closed its previously announced underwritten...
Express News | Mediaalpha Announces Closing of Secondary Offering by White Mountains Insurance Group and Insignia Capital Group
Shareholders May Be Wary Of Increasing MediaAlpha, Inc.'s (NYSE:MAX) CEO Compensation Package
MediaAlpha To Present at Upcoming Investor Conferences
LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- MediaAlpha, Inc. (NYSE: MAX) today announced that management will present at the following upcoming investor conferences: 52nd Annual J.P. Morgan Global
MediaAlpha and ArcBest Have Been Highlighted as Zacks Bull and Bear of the Day
Comments
Investors express uncertainty about MediaAlpha's ability to meet growth expectations despite the stock's momentum and promising future revenue. The contrast of strong revenue outlook with the company's past performance may put pressure on the P/S ratio, signaling potential future revenue volatility.
Investors Still Aren't Entirely Convinced By MediaAlpha, Inc.'s (NYSE:MAX) Revenues Despite 30% Price Jump
TOP WATCH 2/24 + plays today 👍🏼 including AMAM explosion (3 alerts of it this week ⭐️)
AMAM 50%+ RUN 18% LHDX 17%
$Akebia Therapeutics(AKBA.US$ $AutoNation(AN.US$ $Cingulate(CING.US$ $Carvana(CVNA.US$ $Cyren(CYRN.US$ $Expedia(EXPE.US$ $Terran Orbital(LLAP.US$ $Intuitive Machines(LUNR.US$ $MediaAlpha(MAX.US$ $Ocean Biomedical(OCEA.US$ $SatixFy Communications(SATX.US$ $Starbucks(SBUX.US$ $Sellas Life Sciences(SLS.US$ $Vascular Biogenics(VBLT.US$
AMAM 50%+ RUN 18% LHDX 17%
$Akebia Therapeutics(AKBA.US$ $AutoNation(AN.US$ $Cingulate(CING.US$ $Carvana(CVNA.US$ $Cyren(CYRN.US$ $Expedia(EXPE.US$ $Terran Orbital(LLAP.US$ $Intuitive Machines(LUNR.US$ $MediaAlpha(MAX.US$ $Ocean Biomedical(OCEA.US$ $SatixFy Communications(SATX.US$ $Starbucks(SBUX.US$ $Sellas Life Sciences(SLS.US$ $Vascular Biogenics(VBLT.US$
3
1
Read more